Skip to content
TrialScanner

NCT07159828

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Phase 1TerminatedTILCollaborator

Registry record

Lead sponsor
Axion Bio, Inc
Conditions
Solid Tumor, Adult
Primary completion
Apr 16, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT07159828 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT07159828: A Study to Assess AXN-2510... | TrialScanner